293 related articles for article (PubMed ID: 16228654)
1. Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers.
Shibuya S; Wakayama Y; Inoue M; Kojima H; Oniki H
Med Electron Microsc; 2003 Dec; 36(4):213-20. PubMed ID: 16228654
[TBL] [Abstract][Full Text] [Related]
2. A comparative freeze-fracture study of plasma membrane of dystrophic skeletal muscles in dy/dy mice with merosin (laminin 2) deficiency and mdx mice with dystrophin deficiency.
Shibuya S; Wakayama Y; Oniki H; Kojima H; Saito M; Etou T; Nonaka I
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):123-31. PubMed ID: 9160897
[TBL] [Abstract][Full Text] [Related]
3. Immunogold and freeze etch electron microscopic studies of merosin localization in basal lamina of human skeletal muscle fibers.
Wakayama Y; Murahashi M; Jimi T; Kojima H; Shibuya S; Oniki H
Acta Neuropathol; 1997 Jan; 93(1):34-42. PubMed ID: 9006655
[TBL] [Abstract][Full Text] [Related]
4. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
5. Reduced density of intramembranous particle clusters: freeze-fracture study of mdx mouse muscle plasma membrane.
Shibuya S; Wakayama Y; Oniki H
Med Electron Microsc; 2003 Mar; 36(1):59-65. PubMed ID: 12658353
[TBL] [Abstract][Full Text] [Related]
6. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
Patton BL; Wang B; Tarumi YS; Seburn KL; Burgess RW
J Cell Sci; 2008 May; 121(Pt 10):1593-604. PubMed ID: 18430779
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of diaphragm muscle in alpha2-laminin (merosin)-deficient dy/dy dystrophic mice.
van Lunteren E; Moyer M; Leahy P
Physiol Genomics; 2006 Mar; 25(1):85-95. PubMed ID: 16368874
[TBL] [Abstract][Full Text] [Related]
8. [Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].
Smeyers P
Rev Neurol; 1999 Jan 16-31; 28(2):141-9. PubMed ID: 10101782
[TBL] [Abstract][Full Text] [Related]
9. Merosin and congenital muscular dystrophy.
Miyagoe-Suzuki Y; Nakagawa M; Takeda S
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):181-91. PubMed ID: 10679965
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle.
Cullen MJ; Walsh J; Roberds SL; Campbell KP
Neuropathol Appl Neurobiol; 1996 Feb; 22(1):30-7. PubMed ID: 8866780
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice.
Bentzinger CF; Barzaghi P; Lin S; Ruegg MA
FASEB J; 2005 Jun; 19(8):934-42. PubMed ID: 15923403
[TBL] [Abstract][Full Text] [Related]
12. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP
Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103
[TBL] [Abstract][Full Text] [Related]
13. Marked reduction of focal adhesion kinase, serum response factor and myocyte enhancer factor 2C, but increase in RhoA and myostatin in the hindlimb dy mouse muscles.
Sakuma K; Nakao R; Inashima S; Hirata M; Kubo T; Yasuhara M
Acta Neuropathol; 2004 Sep; 108(3):241-9. PubMed ID: 15221330
[TBL] [Abstract][Full Text] [Related]
14. Differential heparin sensitivity of alpha-dystroglycan binding to laminins expressed in normal and dy/dy mouse skeletal muscle.
McDearmon EL; Burwell AL; Combs AC; Renley BA; Sdano MT; Ervasti JM
J Biol Chem; 1998 Sep; 273(37):24139-44. PubMed ID: 9727035
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus.
Sunada Y; Bernier SM; Kozak CA; Yamada Y; Campbell KP
J Biol Chem; 1994 May; 269(19):13729-32. PubMed ID: 8188645
[TBL] [Abstract][Full Text] [Related]
16. Sternohyoid muscle fatigue properties of dy/dy dystrophic mice, an animal model of merosin-deficient congenital muscular dystrophy.
van Lunteren E; Moyer M
Pediatr Res; 2003 Oct; 54(4):547-53. PubMed ID: 12840158
[TBL] [Abstract][Full Text] [Related]
17. Improved muscle strength and mobility in the dy(2J)/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate.
Dadush O; Aga-Mizrachi S; Ettinger K; Tabakman R; Elbaz M; Fellig Y; Yanay N; Nevo Y
Neuromuscul Disord; 2010 Apr; 20(4):267-72. PubMed ID: 20304648
[TBL] [Abstract][Full Text] [Related]
18. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
19. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
Moll J; Barzaghi P; Lin S; Bezakova G; Lochmüller H; Engvall E; Müller U; Ruegg MA
Nature; 2001 Sep; 413(6853):302-7. PubMed ID: 11565031
[TBL] [Abstract][Full Text] [Related]
20. The AChE membrane-binding tail PRiMA is down-regulated in muscle and nerve of mice with muscular dystrophy by merosin deficiency.
Vidal CJ; Montenegro MF; Muñoz-Delgado E; Campoy FJ; Cabezas-Herrera J; Moral-Naranjo MT
Chem Biol Interact; 2013 Mar; 203(1):330-4. PubMed ID: 22906800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
